Stock analysts at Cantor Fitzgerald began coverage on shares of TriSalus Life Sciences (NASDAQ:TLSI – Get Free Report) in a research note issued on Tuesday, Marketbeat.com reports. The brokerage set ...

The median hepatic progression-free survival was 9.3 months, and the median extrahepatic progression-free survival was 16.4 months. A protocol integrating radiosensitizing chemotherapy with ...

Walleye Capital LLC bought a new stake in shares of TriSalus Life Sciences, Inc. (NASDAQ:TLSI – Free Report) in the third ...

The team is effectively utilizing its experience from TheraSphere which makes Y-90 which is a targeted radioembolization ... liver cells, are not reacting to the melphalan. Only the cancer cells ...

A new device is now available for treating advanced liver cancer at home using electromagnetic waves, the Barbara Ann ...

Liver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be ...

It uses electromagnetic waves to target tumors and is available to patients for whom first- and second-line treatments have ...

How would you summarize your study for a lay audience? Immunotherapy has revolutionized the management of cancer, including liver malignancies. However, the benefits are limited by multiple mechanisms ...

After Randy Moss announced an ongoing health battle last week, his son is dispelling reports that he has liver cancer. On Tuesday, Larry Fitzgerald Sr., the father of former NFL player Larry ...

ALASTAIR Cook was told he had terminal liver cancer in July 2024. His devastating diagnosis was caused by a 'silent killer' virus he got after a traumatic car crash almost four decades earlier.

Specially packaged DNA secreted by tumor cells can trigger an immune response that inhibits the metastatic spread of the tumor to the liver, according to a study led by researchers at Weill Cornell ...